Trials / Completed
CompletedNCT04256408
Mind The Gap - Crossing Borders Study
Bronchoscopic Conversion of Collateral Ventilation in CV-positive Emphysema Patients Before Endobronchial Valve Treatment - Mind The Gap Crossing Borders Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
Rationale: A big step forward and great opportunity to improve overall efficacy of bronchoscopic lung volume reductioen is to combine treatment modalities aiming to close the dependent collateral channels and then proceed with EBV therapy to induce lobar collapse, and thus maximal treatment effect. Objective: Primary objective: 1. To investigate the feasibility of injecting AeriSeal into the interlobar collateral ventilation channels region to make the target lobe suitable for endobronchial valve treatment. Secondary objectives: 2. To investigate the safety of injecting AeriSeal into the interlobar collateral ventilation channels region to make the target lobe suitable for endobronchial valve treatment. 3. To investigate the effectiveness of injecting AeriSeal into the interlobar collateral ventilation channels region to make the target lobe suitable for endobronchial valve treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bronchoscopic transparenchymal interlobar fissure closure using Aeriseal | Transbronchial or transparenchymal injection of AeriSeal into the interlobar collateral ventilation channels region to convert CV-positive lobes into CV-negative lobes. |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
- First posted
- 2020-02-05
- Last updated
- 2024-07-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04256408. Inclusion in this directory is not an endorsement.